Tumor-associated macrophages: effectors of angiogenesis and tumor progression.

Tumor-associated macrophages (TAMs) are a prominent inflammatory cell population in many tumor types residing in both perivascular and avascular, hypoxic regions of these tissues. Analysis of TAMs in human tumor biopsies has shown that they express a variety of tumor-promoting factors and evidence from transgenic murine tumor models has provided unequivocal evidence for the importance of these cells in driving angiogenesis, lymphangiogenesis, immunosuppression, and metastasis. This review will summarize the mechanisms by which monocytes are recruited into tumors, their myriad, tumor-promoting functions within tumors, and the influence of the tumor microenvironment in driving these activities. We also discuss recent attempts to both target/destroy TAMs and exploit them as delivery vehicles for anti-cancer gene therapy.

[1]  P. Allavena,et al.  IL‐10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages , 1998, European journal of immunology.

[2]  Barbara Bottazzi,et al.  Autocrine Production of IL-10 Mediates Defective IL-12 Production and NF-κB Activation in Tumor-Associated Macrophages1 , 2000, The Journal of Immunology.

[3]  Masahiro Inoue,et al.  An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. , 2004, The Journal of clinical investigation.

[4]  A. Mantovani,et al.  Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft. , 2007, The Journal of investigative dermatology.

[5]  J. Nyhus,et al.  Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process. , 2002, Cancer research.

[6]  J. Ochoa,et al.  l-Arginine Consumption by Macrophages Modulates the Expression of CD3ζ Chain in T Lymphocytes1 , 2003, The Journal of Immunology.

[7]  R. Ádány,et al.  Tumor‐infiltrating myeloid‐derived suppressor cells are pleiotropic‐inflamed monocytes/macrophages that bear M1‐ and M2‐type characteristics , 2008, Journal of leukocyte biology.

[8]  J. Dobson,et al.  A novel magnetic approach to enhance the efficacy of cell-based gene therapies , 2008, Gene Therapy.

[9]  G. von Minckwitz,et al.  Transforming growth factor-beta stimulates urokinase expression in tumor-associated macrophages of the breast. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[10]  T. Ottenhoff,et al.  Human Anti-Inflammatory Macrophages Induce Foxp3+GITR+CD25+ Regulatory T Cells, Which Suppress via Membrane-Bound TGFβ-11 , 2008, The Journal of Immunology.

[11]  L. Trümper,et al.  Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases. , 2004, Carcinogenesis.

[12]  S. Takeno,et al.  Prognostic significance of CD8+ T cell and macrophage peritumoral infiltration in colorectal cancer. , 2003, Oncology reports.

[13]  F. Balkwill.  Cancer and the chemokine network , 2004, Nature Reviews Cancer.

[14]  Alberto Mantovani,et al.  Inflammation and cancer: back to Virchow? , 2001, The Lancet.

[15]  N. Jonjić,et al.  Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinoma , 2002, Virchows Archiv.

[16]  S. Gordon,et al.  Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.

[17]  G. Soma,et al.  The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients. , 2003, Anticancer research.

[18]  S. Verbeek,et al.  Experimental Antibody Therapy of Liver Metastases Reveals Functional Redundancy between FcγRI and FcγRIV1 , 2008, The Journal of Immunology.

[19]  A. Sica,et al.  Plasticity of Macrophage Function during Tumor Progression: Regulation by Distinct Molecular Mechanisms1 , 2008, The Journal of Immunology.

[20]  Matthew J. Craig,et al.  Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo. , 2007, Cancer research.

[21]  J. Nyhus,et al.  Promotion of tumor invasion by cooperation of granulocytes and macrophages activated by anti-tumor antibodies. , 1999, Neoplasia.

[22]  S. Leibovich,et al.  Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway. , 1998, The American journal of pathology.

[23]  J. Peterson,et al.  Post-transcriptional effects of extracellular pH on tumour necrosis factor-alpha production in RAW 246.7 and J774 A.1 cells. , 2001, Clinical science.

[24]  G. Ahn,et al.  Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. , 2008, Cancer cell.

[25]  A. Sica,et al.  Altered macrophage differentiation and immune dysfunction in tumor development. , 2007, The Journal of clinical investigation.

[26]  A. Harris,et al.  The macrophage – a novel system to deliver gene therapy to pathological hypoxia , 2000, Gene Therapy.

[27]  George Coukos,et al.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival , 2004, Nature Medicine.

[28]  J. Fleming,et al.  Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice. , 2008, Cancer research.

[29]  B. Passlick,et al.  Identification and characterization of a novel monocyte subpopulation in human peripheral blood. , 1989, Blood.

[30]  E. Kay,et al.  Effect of neoadjuvant chemoradiotherapy on angiogenesis in oesophageal cancer , 2003, The British journal of surgery.

[31]  P. Allavena,et al.  Defective Expression of the Monocyte Chemotactic Protein-1 Receptor CCR2 in Macrophages Associated with Human Ovarian Carcinoma1 , 2000, The Journal of Immunology.

[32]  M. Flister,et al.  Anti‐VEGF‐A therapy reduces lymphatic vessel density and expression of VEGFR‐3 in an orthotopic breast tumor model , 2007, International journal of cancer.

[33]  G. Zhu,et al.  Relationship between B7-H4, regulatory T cells, and patient outcome in human ovarian carcinoma. , 2007, Cancer research.

[34]  C. Lewis,et al.  Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy. , 2003, The American journal of pathology.

[35]  K. Matsushima,et al.  CCL3-CCR5 Axis Regulates Intratumoral Accumulation of Leukocytes and Fibroblasts and Promotes Angiogenesis in Murine Lung Metastasis Process1 , 2008, The Journal of Immunology.

[36]  Andrew V. Nguyen,et al.  The Macrophage Growth Factor CSF-1 in Mammary Gland Development and Tumor Progression , 2002, Journal of Mammary Gland Biology and Neoplasia.

[37]  M. Simon,et al.  Hypoxia-inducible factors: central regulators of the tumor phenotype. , 2007, Current opinion in genetics & development.

[38]  C. Lewis,et al.  Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies. , 2005, The American journal of pathology.

[39]  P. De Baetselier,et al.  Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. , 2008, Blood.

[40]  D. Gabrilovich,et al.  STAT1 Signaling Regulates Tumor-Associated Macrophage-Mediated T Cell Deletion1 , 2005, The Journal of Immunology.

[41]  Laurence Zitvogel,et al.  Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy , 2007, Nature Medicine.

[42]  A. Chadli.  THE CANCER CELL , 1924, La Presse medicale.

[43]  J. Talmadge,et al.  Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice. , 2008, Blood.

[44]  Zhijin Wu,et al.  Targeting tumor-associated macrophages in an orthotopic murine model of diffuse malignant mesothelioma , 2008, Molecular Cancer Therapeutics.

[45]  K. Alitalo,et al.  Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. , 2002, The American journal of pathology.

[46]  B. Fingleton,et al.  Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. , 2004, Cancer cell.

[47]  J. Pollard,et al.  Distinct role of macrophages in different tumor microenvironments. , 2006, Cancer research.

[48]  C. Lewis,et al.  Expression of Tie-2 by Human Monocytes and Their Responses to Angiopoietin-21 , 2007, The Journal of Immunology.

[49]  Hiroyuki Aburatani,et al.  Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis , 2006, Nature Cell Biology.

[50]  G. Meijer,et al.  Macrophages direct tumour histology and clinical outcome in a colon cancer model , 2005, The Journal of pathology.

[51]  K. Alitalo,et al.  Metastasis: Lymphangiogenesis and cancer metastasis , 2002, Nature Reviews Cancer.

[52]  G. Stamp,et al.  Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. , 1997, The American journal of pathology.

[53]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[54]  W. Jochum,et al.  Serotonin regulates macrophage-mediated angiogenesis in a mouse model of colon cancer allografts. , 2008, Cancer research.

[55]  Fabian Kiessling,et al.  Flt-1 signaling in macrophages promotes glioma growth in vivo. , 2008, Cancer research.

[56]  Mallika Singh,et al.  Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression , 2008, Proceedings of the National Academy of Sciences.

[57]  M. Reed,et al.  Macrophages promote angiogenesis in human breast tumour spheroids in vivo , 2005, British Journal of Cancer.

[58]  T. Timme,et al.  Macrophages transduced with an adenoviral vector expressing interleukin 12 suppress tumor growth and metastasis in a preclinical metastatic prostate cancer model. , 2003, Cancer research.

[59]  T. Hagemann,et al.  Macrophages Induce Invasiveness of Epithelial Cancer Cells Via NF-κB and JNK1 , 2005, The Journal of Immunology.

[60]  D. Quiceno,et al.  L-arginine availability regulates T-lymphocyte cell-cycle progression. , 2007, Blood.

[61]  P. Comoglio,et al.  Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages , 2008, The Journal of experimental medicine.

[62]  A. Griffioen,et al.  Monocyte/macrophage infiltration in tumors: modulators of angiogenesis , 2006, Journal of leukocyte biology.

[63]  F. Peale,et al.  Bv8 regulates myeloid-cell-dependent tumour angiogenesis , 2007, Nature.

[64]  T. Lucas,et al.  Target validation using RNA interference in solid tumors. , 2007, Methods in molecular biology.

[65]  C. Civin,et al.  Flow cytometric analysis of human bone marrow. IV. Differential quantitative expression of T-200 common leukocyte antigen during normal hemopoiesis. , 1988, Journal of immunology.

[66]  C. Liu,et al.  Targeting tumor-associated macrophages as a novel strategy against breast cancer. , 2006, The Journal of clinical investigation.

[67]  A. Harris,et al.  Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast , 1999, British Journal of Cancer.

[68]  Madeleine Moussa,et al.  Hypoxia-induced, perinecrotic expression of endothelial Per-ARNT-Sim domain protein-1/hypoxia-inducible factor-2alpha correlates with tumor progression, vascularization, and focal macrophage infiltration in bladder cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[69]  Craig Murdoch,et al.  Macrophage migration and gene expression in response to tumor hypoxia , 2005, International journal of cancer.

[70]  C. Lewis,et al.  Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. , 2004, Blood.

[71]  J. Pollard.  Tumour-educated macrophages promote tumour progression and metastasis , 2004, Nature Reviews Cancer.

[72]  J. Pollard,et al.  A Paracrine Loop between Tumor Cells and Macrophages Is Required for Tumor Cell Migration in Mammary Tumors , 2004, Cancer Research.

[73]  Remo Guidieri.  Res , 1995, RES: Anthropology and Aesthetics.

[74]  J. Pollard,et al.  Macrophages regulate the angiogenic switch in a mouse model of breast cancer. , 2006, Cancer research.

[75]  K. Shirouzu,et al.  Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesis , 2007, Cancer science.

[76]  L. Trümper,et al.  Wnt 5a signaling is critical for macrophage-induced invasion of breast cancer cell lines. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[77]  L. Naldini,et al.  Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells , 2003, Nature Medicine.

[78]  L. Varesio,et al.  Hypoxia inhibits the expression of the CCR5 chemokine receptor in macrophages. , 2004, Cellular immunology.

[79]  S. Rafii,et al.  VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.

[80]  I. Takanami,et al.  Tumor-Associated Macrophage Infiltration in Pulmonary Adenocarcinoma: Association with Angiogenesis and Poor Prognosis , 1999, Oncology.

[81]  E. Stanley,et al.  Colony-stimulating factor-1 antisense treatment suppresses growth of human tumor xenografts in mice. , 2002, Cancer research.

[82]  Shigeyoshi Itohara,et al.  Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.

[83]  L. Coussens,et al.  Paradoxical roles of the immune system during cancer development , 2006, Nature Reviews Cancer.

[84]  K. Nakashiro,et al.  Infiltration of tumor-associated macrophages in human oral squamous cell carcinoma. , 2002, Oncology reports.

[85]  P. Sinha,et al.  Reduction of Myeloid-Derived Suppressor Cells and Induction of M1 Macrophages Facilitate the Rejection of Established Metastatic Disease1 , 2005, The Journal of Immunology.

[86]  L. Naldini,et al.  Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications. , 2007, Trends in immunology.

[87]  Craig Murdoch,et al.  Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response. , 2008, Neoplasia.

[88]  C. Chiang,et al.  Macrophages from irradiated tumors express higher levels of iNOS, arginase-I and COX-2, and promote tumor growth. , 2007, International journal of radiation oncology, biology, physics.

[89]  R. Reed,et al.  Inhibition of carcinoma cell‐derived VEGF reduces inflammatory characteristics in xenograft carcinoma , 2006, International journal of cancer.

[90]  Marian Taylor,et al.  Relation of Hypoxia-inducible Factor-2α (HIF-2α) Expression in Tumor-infiltrative Macrophages to Tumor Angiogenesis and the Oxidative Thymidine Phosphorylase Pathway in Human Breast Cancer , 2002 .

[91]  A. Harris,et al.  Expression of vascular endothelial growth factor by macrophages is up‐regulated in poorly vascularized areas of breast carcinomas , 2000, The Journal of pathology.

[92]  A. Harris,et al.  Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. , 1996, Cancer research.

[93]  Erik Sahai,et al.  Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. , 2005, Cancer research.

[94]  G. Soma,et al.  Correlation of histological localization of tumor-associated macrophages with clinicopathological features in endometrial cancer. , 2004, Anticancer research.

[95]  Katerina Akassoglou,et al.  NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α , 2008, Nature.

[96]  Michelle Collazo,et al.  Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice1 , 2008, The Journal of Immunology.

[97]  J. Ochoa,et al.  L-Arginine modulates CD3zeta expression and T cell function in activated human T lymphocytes. , 2004, Cellular immunology.

[98]  M. Shibuya,et al.  MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. , 2002, Cancer cell.

[99]  C. Lewis,et al.  Hypoxia Regulates Macrophage Functions in Inflammation1 , 2005, The Journal of Immunology.

[100]  H. Cha,et al.  Profound but dysfunctional lymphangiogenesis via vascular endothelial growth factor ligands from CD11b+ macrophages in advanced ovarian cancer. , 2008, Cancer research.

[101]  Kristi Kincaid,et al.  M-1/M-2 Macrophages and the Th1/Th2 Paradigm1 , 2000, The Journal of Immunology.

[102]  H. Fujii,et al.  Characteristic alteration of monocytes with increased intracellular IL-10 and IL-12 in patients with advanced-stage gastric cancer. , 2004, The Journal of surgical research.

[103]  A. Mantovani,et al.  Smoldering and polarized inflammation in the initiation and promotion of malignant disease. , 2005, Cancer cell.

[104]  S. Gordon.  Alternative activation of macrophages , 2003, Nature Reviews Immunology.

[105]  G. Fuh,et al.  Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells , 2007, Nature Biotechnology.

[106]  S. Vandenberg,et al.  HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. , 2008, Cancer cell.

[107]  Gefeng Zhu,et al.  B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma , 2006, The Journal of experimental medicine.

[108]  S. Gordon,et al.  Ovarian Cancer Cells Polarize Macrophages Toward A Tumor-Associated Phenotype1 , 2006, The Journal of Immunology.

[109]  S. Coffelt,et al.  Tumors sound the alarmin(s). , 2008, Cancer research.

[110]  Paolo Serafini,et al.  Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. , 2006, The Journal of clinical investigation.

[111]  H. Hamada,et al.  Induction of potent antitumor response by vaccination with tumor lysate-pulsed macrophages engineered to secrete macrophage colony-stimulating factor and interferon-γ , 2000, Gene Therapy.

[112]  Hua Yu,et al.  Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity , 2005, Nature Medicine.

[113]  A. Harris,et al.  The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages , 2000 .

[114]  P. Carmeliet,et al.  The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironment , 2008, The Journal of experimental medicine.

[115]  Steffen Jung,et al.  Blood monocytes consist of two principal subsets with distinct migratory properties. , 2003, Immunity.

[116]  M. Nakagawa,et al.  Prognostic value of tumor‐associated macrophage count in human bladder cancer , 2000, International journal of urology : official journal of the Japanese Urological Association.

[117]  M. Giacca,et al.  Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels , 2007, Cell.

[118]  Luigi Naldini,et al.  Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. , 2005, Cancer cell.

[119]  A. Sica,et al.  A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). , 2006, Blood.

[120]  A. Cumano,et al.  Monitoring of Blood Vessels and Tissues by a Population of Monocytes with Patrolling Behavior , 2007, Science.

[121]  T. Lawrence,et al.  “Re-educating” tumor-associated macrophages by targeting NF-κB , 2008, The Journal of experimental medicine.

[122]  R. Wiltrout,et al.  Augmentation of metastasis formation by thioglycollate‐elicited macrophages , 1982, International journal of cancer.

[123]  A. Giatromanolaki,et al.  Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesis , 2002, British Journal of Cancer.

[124]  Andrea Falini,et al.  Tumor-targeted interferon-alpha delivery by Tie2-expressing monocytes inhibits tumor growth and metastasis. , 2008, Cancer cell.

[125]  C. Mundy,et al.  Genetic amplification of the transcriptional response to hypoxia as a novel means of identifying regulators of angiogenesis. , 2004, Genomics.

[126]  P. Sinha,et al.  Interleukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis. , 2005, Cancer research.

[127]  D. Wink,et al.  Thrombospondin 1 promotes tumor macrophage recruitment and enhances tumor cell cytotoxicity of differentiated U937 cells. , 2008, Cancer research.

[128]  C. Lewis,et al.  Effects of hypoxia on transcription factor expression in human monocytes and macrophages. , 2008, Immunobiology.

[129]  Luigi Naldini,et al.  Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer. , 2007, Blood.

[130]  Christopher Chiu,et al.  Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis , 2006, Proceedings of the National Academy of Sciences.

[131]  Jason A. Skinner,et al.  Bordetella bronchiseptica Modulates Macrophage Phenotype Leading to the Inhibition of CD4+ T Cell Proliferation and the Initiation of a Th17 Immune Response1 , 2006, The Journal of Immunology.

[132]  P. Allavena,et al.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. , 2002, Trends in immunology.

[133]  Andrew V. Nguyen,et al.  Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy , 2001, The Journal of experimental medicine.

[134]  A. Hauschild,et al.  Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes , 2005, Modern Pathology.

[135]  Luigi Minerba,et al.  The predictive value of CD8, CD4, CD68, and human leukocyte antigen‐D‐related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase , 2005, Cancer.

[136]  Hiroyuki Aburatani,et al.  The S100A8–serum amyloid A3–TLR4 paracrine cascade establishes a pre-metastatic phase , 2008, Nature Cell Biology.

[137]  L. Coussens,et al.  Inflammation and cancer , 2002, Nature.

[138]  T. Misteli,et al.  Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.

[139]  Yarong Wang,et al.  Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. , 2007, Cancer research.

[140]  Z. Werb,et al.  Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma. , 2007, Cancer research.

[141]  Tomoyuki Shirai,et al.  MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL. , 2005, Cancer cell.

[142]  D. Hanahan,et al.  MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis , 2000, Cell.

[143]  O. Vasiljeva,et al.  Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer. , 2006, Cancer research.

[144]  Noam Brown,et al.  The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies , 2002, The Journal of pathology.

[145]  R. Schwendener,et al.  Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach , 2006, British Journal of Cancer.

[146]  Silvano Sozzani,et al.  The chemokine system in diverse forms of macrophage activation and polarization. , 2004, Trends in immunology.

[147]  R. Apte,et al.  Effect of senescence on macrophage polarization and angiogenesis. , 2008, Rejuvenation research.

[148]  David A. Cheresh,et al.  Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin , 2007, Nature.

[149]  M. Haine,et al.  Van Damme A. , 1986 .

[150]  P. Rogalla,et al.  Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule. , 2005, The American journal of pathology.

[151]  S. Stohlman,et al.  In vivo effects of T helper cell type 2 cytokines on macrophage antigen-presenting cell induction of T helper subsets. , 1997, Journal of immunology.